Clinical manifestations and laboratory data of subacute cutaneous lupus erythematosus
Molad, Y.; Weinberger, A.; David, M.; Garty, B.; Wysenbeek, A.J.; Pinkhas, J.
Israel Journal of Medical Sciences 23(4): 278-280
1987
ISSN/ISBN: 0021-2180 PMID: 3305416 Document Number: 289860
Nine patients with subacute cutaneous lupus erythematosus (SCLE) are described, all of whom had systemic involvement of the disease although usually milder than in systemic lupus erythematosus. None of the patients had renal disease or died of SCLE.
Document emailed within 1 workday
Related Documents
Bardach, H. 1982: ANF-negative subacute cutaneous lupus erythematosus with anti-Ro antibodies. a new subset of lupus with characteristic skin manifestations Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 33(10): 537-541Sönnichsen, N.; Meffert, H.; Kunzelmann, V.; Audring, H. 1993: UV-A-1 therapy of subacute cutaneous lupus erythematosus Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 44(11): 723-725
Maguiness, S.M.; Farsani, T.T.; Zedek, D.C.; Berger, T.G. 2015: Imiquimod-induced subacute cutaneous lupus erythematosus-like changes Cutis 95(6): 349-351
Boyd, A.S.; Zemtsov, A.; Neldner, K.H. 1993: Pityriasis rubra pilaris presenting as subacute cutaneous lupus erythematosus Cutis 52(3): 177-179
Tebbe, B.; Hoffmann, S.; Orfanos, C.E. 1994: Course and prognosis of subacute cutaneous lupus erythematosus. A prospective study of 34 patients Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 45(10): 690-695
Burnett, T.J.; English, J.C.; Ferris, L.K. 2010: Development of subacute cutaneous lupus erythematosus associated with the use of imiquimod to treat actinic keratoses Journal of Drugs in Dermatology: Jdd 9(8): 1022-1024
Chen, M.; Crowson, A.Neil.; Woofter, M.; Luca, M.Beth.; Magro, C.M. 2004: Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases Journal of Rheumatology 31(4): 818-820
Camp, P.B.; Davis, L.S. 1997: "Coexistence of subacute cutaneous lupus erythematosus and porphyria cutanea tarda: a case report" Cutis 59(4): 216e
Wenzel, J.; Bauer, R.; Bieber, T.; Boehm, I. 2000: Discoid and subacute cutaneous lupus erythematosus: detection of differences in peripheral lymphocyte numbers ActaDermato-Venereologica 80(6): 456
Schairer, D.; Friedman, A. 2011: Manifestations and treatment of cutaneous lupus erythematosus (Part Ii of II) Journal of Drugs in Dermatology: Jdd 10(12): 1474-1476
Schairer, D.; Friedman, A. 2011: Manifestations and treatment of cutaneous lupus erythematosus (part i of II) Journal of Drugs in Dermatology: Jdd 10(10): 1212-1214
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Pothinamthong, P.; Janjumratsang, P. 2012: A comparative study in efficacy and safety of 0.1% tacrolimus and 0.05% clobetasol propionate ointment in discoid lupus erythematosus by modified cutaneous lupus erythematosus disease area and severity index Journal of the Medical Association of Thailand 95(7): 933-940
Chunharas, A.; Nuntnarumit, P.; Hongeng, S.; Chaunsumrit, A. 2002: Neonatal lupus erythematosus: clinical manifestations and management Journal of the Medical Association of Thailand 85(Suppl 4): S1302-S1308
Ward, M.M.; Studenski, S. 1990: Age associated clinical manifestations of systemic lupus erythematosus: a multivariate regression analysis Journal of Rheumatology 17(4): 476-481
Ahmed, T.A.; Ikram, N.; Hussain, T.; Farooqui, A.; Haleem, A.; Bashir, M.; Moin, S.; Karamat, K.A. 2002: Clinical and laboratory features of systemic lupus erythematosus (SLE) in Pakistani patients Jpma. Journal of the Pakistan Medical Association 52(1): 12-15
Rodríguez-Valverde, V.; Peña Sagredo, J.L.; Orte Martínez, J.; Novo Fernández, M.J.; Sánchez Andrada, S.; Sampedro Alvarez, J. 1982: Circulating immune complexes and C3 in patients with systemic lupus erythematosus. the relationship between clinical manifestations and nephropathy Medicina Clinica 78(9): 353-357
Rauch, J.; Hazeltine, M.; Tannenbaum, H.; Danoff, D.; Isenberg, D.A.; Wild, J.; Sampalis, J.; Esdaile, J.M. 1990: Association of anti-DNA idiotype markers with clinical and serological manifestations in patients with systemic lupus erythematosus Journal of Rheumatology 17(2): 178-185
Costallat, L.T.; Coimbra, A.M. 1994: Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset Clinical and Experimental Rheumatology 12(6): 603-607
Lusins, J.O.; Szilagyi, P.A.; Etess, H.B.; Platt, N.; Nathanson, M. 1973: Clinical features and histological data of chorea associated with systemic lupus erythematosus (SLE) Transactions of the American Neurological Association 98: 279-281